Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stattin

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2018
Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. ChenA Pettersson, D Robinson, H Garmo, et al.
BJU International|April 12, 2002
Prognostic value of the Gleason score in prostate cancerL Egevad, T Granfors, L Karlberg, et al.
The Prostate|September 19, 1997
Vascular density is a predictor of cancer-specific survival in prostatic carcinomaI F Lissbrant, P Stattin, J E Damber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2017
Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort studyA Pettersson, D Robinson, H Garmo, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2001
Ratios of IGF-I, IGF binding protein-3, and prostate-specific antigen in prostate cancer detectionP Stattin, U H Stenman, E Riboli, et al.
European Urology|January 1, 1997
Long-term outcome of conservative therapy in men presenting with voiding symptoms and prostate cancerP Stattin, A Bergh, L Karlberg, et al.
Lancet (London, England)|May 3, 2001
Prostate cancer screeningP Stattin, U H Stenman, E Riboli, et al.
The Prostate|March 13, 1999
Early castration-induced upregulation of transforming growth factor beta1 and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patientsP Wikström, P Westin, P Stattin, et al.
Urological Research|January 1, 1996
Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survivalP Stattin, J E Damber, L Karlberg, et al.
BJU International|July 12, 2001
Castration-induced reduction of vascular endothelial growth factor expression in benign human prostate tissue is lost in advanced prostate cancerS Häggström, P Stattin, P Wikström, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 12, 2018
Reply to the letter to the editor 'Age at diagnosis and prognosis among prostate cancer patients treated with radiotherapy: evidenced from three independent cohort studies' by X. Dong, G. Ma and F. ChenA Pettersson, D Robinson, H Garmo, et al.
BJU International|April 12, 2002
Prognostic value of the Gleason score in prostate cancerL Egevad, T Granfors, L Karlberg, et al.
The Prostate|September 19, 1997
Vascular density is a predictor of cancer-specific survival in prostatic carcinomaI F Lissbrant, P Stattin, J E Damber, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 22, 2017
Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort studyA Pettersson, D Robinson, H Garmo, et al.
The Journal of Clinical Endocrinology and Metabolism|December 12, 2001
Ratios of IGF-I, IGF binding protein-3, and prostate-specific antigen in prostate cancer detectionP Stattin, U H Stenman, E Riboli, et al.
European Urology|January 1, 1997
Long-term outcome of conservative therapy in men presenting with voiding symptoms and prostate cancerP Stattin, A Bergh, L Karlberg, et al.
Lancet (London, England)|May 3, 2001
Prostate cancer screeningP Stattin, U H Stenman, E Riboli, et al.
The Prostate|March 13, 1999
Early castration-induced upregulation of transforming growth factor beta1 and its receptors is associated with tumor cell apoptosis and a major decline in serum prostate-specific antigen in prostate cancer patientsP Wikström, P Westin, P Stattin, et al.
Urological Research|January 1, 1996
Bcl-2 immunoreactivity in prostate tumorigenesis in relation to prostatic intraepithelial neoplasia, grade, hormonal status, metastatic growth and survivalP Stattin, J E Damber, L Karlberg, et al.
BJU International|July 12, 2001
Castration-induced reduction of vascular endothelial growth factor expression in benign human prostate tissue is lost in advanced prostate cancerS Häggström, P Stattin, P Wikström, et al.
Pageof 6